Your browser doesn't support javascript.
loading
CCR2+ monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-ß1.
Lebrun, Astrid; Lo Re, Sandra; Chantry, Mathilde; Izquierdo Carerra, Xavier; Uwambayinema, Francine; Ricci, Doriana; Devosse, Raynal; Ibouraadaten, Saloua; Brombin, Lisa; Palmai-Pallag, Mihaly; Yakoub, Yousof; Pasparakis, Manolis; Lison, Dominique; Huaux, François.
Afiliação
  • Lebrun A; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Lo Re S; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Chantry M; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Izquierdo Carerra X; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Uwambayinema F; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Ricci D; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Devosse R; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Ibouraadaten S; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Brombin L; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Palmai-Pallag M; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Yakoub Y; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Pasparakis M; CECAD Research Centre, University of Cologne, Germany.
  • Lison D; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
  • Huaux F; Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Experimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.
J Pathol ; 243(3): 320-330, 2017 11.
Article em En | MEDLINE | ID: mdl-28799208
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Monócitos / Fator de Crescimento Transformador beta1 / Receptores CCR2 / Células Supressoras Mieloides Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Monócitos / Fator de Crescimento Transformador beta1 / Receptores CCR2 / Células Supressoras Mieloides Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica